Cargando…

A novel GTPase, CRAG, mediates promyelocytic leukemia protein–associated nuclear body formation and degradation of expanded polyglutamine protein

Polyglutamine diseases are inherited neurodegenerative diseases caused by the expanded polyglutamine proteins (polyQs). We have identified a novel guanosine triphosphatase (GTPase) named CRAG that contains a nuclear localization signal (NLS) sequence and forms nuclear inclusions in response to stres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Qingyu, Inatome, Ryoko, Hotta, Azusa, Kojima, Masaki, Yamamura, Hirohei, Hirai, Hirokazu, Yoshizawa, Toshihiro, Tanaka, Hirofumi, Fukami, Kiyoko, Yanagi, Shigeru
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063670/ https://www.ncbi.nlm.nih.gov/pubmed/16461359 http://dx.doi.org/10.1083/jcb.200505079

Ejemplares similares

Forebrain-specific deficiency of the GTPase CRAG/Centaurin-γ3 leads to immature dentate gyri and hyperactivity in mice
por: Nagashima, Shun, et al.
Publicado: (2021)

Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies
por: Nagashima, Shun, et al.
Publicado: (2019)

CAMDI interacts with the human memory-associated protein KIBRA and regulates AMPAR cell surface expression and cognition
por: Fukuda, Toshifumi, et al.
Publicado: (2019)

Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones
por: Rousseau, Erwann, et al.
Publicado: (2009)

Crag Martin neontology complements taphonomy at the Gorham's Cave Complex
por: Bensusan, Keith, et al.
Publicado: (2021)

The GTPase domain of Galphao contributes to the functional interaction of Galphao with the promyelocytic leukemia zinc finger protein
por: Won, Jung Hee, et al.
Publicado: (2008)

Climbing crags recommender system in Arco, Italy: a comparative study
por: Ivanova, Iustina, et al.
Publicado: (2023)

Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity
por: Ghosh, Baijayanti, et al.
Publicado: (2021)

Nuclear accumulation of polyglutamine disease proteins and neuropathology
por: Havel, Lauren S, et al.
Publicado: (2009)

Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation
por: Howard, Rebecca A, et al.
Publicado: (2007)

Structure prediction of polyglutamine disease proteins: comparison of methods
por: Wen, Jingran, et al.
Publicado: (2014)

Quantification Assays for Total and Polyglutamine-Expanded Huntingtin Proteins
por: Macdonald, Douglas, et al.
Publicado: (2014)

Evolution and function of CAG/polyglutamine repeats in protein–protein interaction networks
por: Schaefer, Martin H., et al.
Publicado: (2012)

Regulation of B cell differentiation by the ubiquitin-binding protein TAX1BP1
por: Matsushita, Nobuko, et al.
Publicado: (2016)

Crag Is a GEF for Rab11 Required for Rhodopsin Trafficking and Maintenance of Adult Photoreceptor Cells
por: Xiong, Bo, et al.
Publicado: (2012)

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
por: Ramachandran, Anu, et al.
Publicado: (2017)

Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014–2015
por: Haumba, Samson M., et al.
Publicado: (2020)

Nuclear polyglutamine-containing protein aggregates as active proteolytic centers
por: Chen, Min, et al.
Publicado: (2008)

Identifying polyglutamine protein species in situ that best predict neurodegeneration
por: Miller, Jason, et al.
Publicado: (2011)

Proteins with Intrinsically Disordered Domains Are Preferentially Recruited to Polyglutamine Aggregates
por: Wear, Maggie P., et al.
Publicado: (2015)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021)

Oscillation of Cdc20–APC/C–mediated CAMDI stability is critical for cortical neuron migration
por: Okuda, Shohei, et al.
Publicado: (2021)

CRAG: de novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing
por: Zhou, Xionghui, et al.
Publicado: (2022)

Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability
por: Hashimoto, Makoto, et al.
Publicado: (2018)

Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression
por: Suhr, Steven T., et al.
Publicado: (2001)

Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
por: Wang, Adrienne M., et al.
Publicado: (2012)

A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases
por: Johnson, Sean L., et al.
Publicado: (2022)

On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics
por: Conceição, André, et al.
Publicado: (2023)

FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation
por: Furtado, Gabriel Vasata, et al.
Publicado: (2021)

Mitochondrial Dynamics Regulation in Skin Fibroblasts from Mitochondrial Disease Patients
por: Tokuyama, Takeshi, et al.
Publicado: (2020)

Autophagy and polyglutamine diseases
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2012)

Polyglutamine Repeats in Viruses
por: Schein, Catherine H.
Publicado: (2018)

Protective roles of MITOL against myocardial senescence and ischemic injury partly via Drp1 regulation
por: Tokuyama, Takeshi, et al.
Publicado: (2022)

Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity
por: Kvam, Erik, et al.
Publicado: (2009)

HSP70 interacting protein prevents the accumulation of inclusions in polyglutamine disease(1)
por: Howarth, Joanna L, et al.
Publicado: (2009)

Monomeric, Oligomeric and Polymeric Proteins in Huntington Disease and Other Diseases of Polyglutamine Expansion
por: Hoffner, Guylaine, et al.
Publicado: (2014)

Autophagy mediates SUMO-induced degradation of a polyglutamine protein ataxin-3
por: Hwang, Soo Pyung, et al.
Publicado: (2017)

Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases
por: Sambataro, Fabio, et al.
Publicado: (2017)

Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington’s disease
por: Matlahov, Irina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6au0dq2n8a7aicp187f9u4fn33